Sal Trading, LLC Astrazeneca PLC Call Options Transaction History

Sal Trading, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 07, 2024	SELL	$61.03 - $69.57 $1.01 Million - $1.15 Million	-16,600 Reduced 57.04%	12,500 $846,000
Q4 2023 Feb 14, 2024	BUY	$61.89 - $69.28 $1.8 Million - $2.02 Million	29,100 New	29,100 $1.96 Million
Q2 2023 Aug 11, 2023	BUY	$69.91 - $75.81 $9.72 Million - $10.5 Million	139,000 New	139,000 $9.95 Million
Q1 2022 May 16, 2022	BUY	$55.72 - $67.12 $2.23 Million - $2.68 Million	40,000 New	40,000 $2.69 Million

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Sal Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Sal Trading, LLC with notifications on news.